Nikolas I Krieger
Overview
Explore the profile of Nikolas I Krieger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Busch R, Dalton J, Jehi L, Ferguson L, Krieger N, Struck A, et al.
Neurology
. 2023 Apr;
100(23):e2350-e2359.
PMID: 37076308
Background And Objectives: Temporal lobe epilepsy (TLE) is the most common adult form of epilepsy and is associated with a high risk of cognitive deficits and depressed mood. However, little...
2.
Becerril A, Pfoh E, Hashmi A, Mourany L, Gunzler D, Berg K, et al.
J Am Geriatr Soc
. 2023 Mar;
71(8):2406-2418.
PMID: 36928611
Background: Evidence on the effects of neighborhood socioeconomic disadvantage on dementia risk in racially and ethically diverse populations is limited. Our objective was to evaluate the relative extent to which...
3.
Dalton J, Pfoh E, Dawson N, Mourany L, Becerril A, Gunzler D, et al.
Med Decis Making
. 2022 Oct;
42(8):1027-1040.
PMID: 36255188
Background: Electronic health records (EHRs) provide researchers with abundant sample sizes, detailed clinical data, and other advantages for performing high-quality observational health research on diverse populations. We review and demonstrate...
4.
Huded C, Dalton J, Kumar A, Krieger N, Kassis N, Phelan M, et al.
J Am Heart Assoc
. 2021 Nov;
10(24):e024540.
PMID: 34779652
Background We evaluated whether a comprehensive ST-segment-elevation myocardial infarction protocol (CSP) focusing on guideline-directed medical therapy, transradial percutaneous coronary intervention, and rapid door-to-balloon time improves process and outcome metrics in...
5.
Bensken W, Krieger N, Berg K, Einstadter D, Dalton J, Perzynski A
J Health Care Poor Underserved
. 2021 Aug;
32(3):1619-1634.
PMID: 34421052
Using a multi-institutional EMR registry, we extracted housing status and evaluated the presence of several important comorbidities in order to describe the demographics and comorbidity burden of persons experiencing homelessness...
6.
Dalton J, Gunzler D, Jain V, Perzynski A, Dawson N, Einstadter D, et al.
PLoS One
. 2021 Aug;
16(8):e0255343.
PMID: 34351971
Background: Social and ecological differences in early SARS-CoV-2 pandemic screening and outcomes have been documented, but the means by which these differences have arisen are not well understood. Objective: To...
7.
Taksler G, Dalton J, Perzynski A, Rothberg M, Milinovich A, Krieger N, et al.
Med Decis Making
. 2020 Sep;
41(2):133-142.
PMID: 32969760
Electronic health records (EHRs) offer the potential to study large numbers of patients but are designed for clinical practice, not research. Despite the increasing availability of EHR data, their use...
8.
Dalton J, Benish W, Krieger N
Entropy (Basel)
. 2020 Mar;
22(2).
PMID: 32116466
Limitations of statistics currently used to assess balance in observation samples include their insensitivity to shape discrepancies and their dependence upon sample size. The Jensen-Shannon divergence (JSD) is an alternative...
9.
Failure of Traditional Risk Factors to Adequately Predict Cardiovascular Events in Older Populations
Dalton J, Rothberg M, Dawson N, Krieger N, Zidar D, Perzynski A
J Am Geriatr Soc
. 2020 Jan;
68(4):754-761.
PMID: 31958154
Background: Accurate assessment of atherosclerotic cardiovascular disease (ASCVD) risk across heterogeneous populations is needed for effective primary prevention. Little is known about the performance of standard cardiovascular risk factors in...
10.
Zidar D, Al-Kindi S, Liu Y, Krieger N, Perzynski A, Osnard M, et al.
JAMA Netw Open
. 2019 Dec;
2(12):e1916526.
PMID: 31790569
Importance: Immune dysregulation can increase the risk of infection, malignant neoplasms, and cardiovascular disease, but improved methods are needed to identify and quantify immunologic hazard in the general population. Objective:...